Department of Biophysics, Panjab University, Chandigarh, India.
Centre for Biomedical Engineering, Indian Institute of Technology, New Delhi, India.
Eur J Med Res. 2023 Aug 30;28(1):307. doi: 10.1186/s40001-023-01293-2.
Coronaviruses such as Severe Acute Respiratory Syndrome coronavirus (SARS), Middle Eastern Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are associated with critical illnesses, including severe respiratory disorders. SARS-CoV-2 is the causative agent of the deadly COVID-19 illness, which has spread globally as a pandemic. SARS-CoV-2 may enter the human body through olfactory lobes and interact with the angiotensin-converting enzyme2 (ACE2) receptor, further facilitating cell binding and entry into the cells. Reports have shown that the virus can pass through the blood-brain barrier (BBB) and enter the central nervous system (CNS), resulting in various disorders. Cell entry by SARS-CoV-2 largely relies on TMPRSS2 and cathepsin L, which activate S protein. TMPRSS2 is found on the cell surface of respiratory, gastrointestinal and urogenital epithelium, while cathepsin-L is a part of endosomes.
The current review aims to provide information on how SARS-CoV-2 infection affects brain function.. Furthermore, CNS disorders associated with SARS-CoV-2 infection, including ischemic stroke, cerebral venous thrombosis, Guillain-Barré syndrome, multiple sclerosis, meningitis, and encephalitis, are discussed. The many probable mechanisms and paths involved in developing cerebrovascular problems in COVID patients are thoroughly detailed.
There have been reports that the SARS-CoV-2 virus can cross the blood-brain barrier (BBB) and enter the central nervous system (CNS), where it could cause a various illnesses. Patients suffering from COVID-19 experience a range of neurological complications, including sleep disorders, viral encephalitis, headaches, dysgeusia, and cognitive impairment. The presence of SARS-CoV-2 in the cerebrospinal fluid (CSF) of COVID-19 patients has been reported. Health experts also reported its presence in cortical neurons and human brain organoids. The possible mechanism of virus infiltration into the brain can be neurotropic, direct infiltration and cytokine storm-based pathways. The olfactory lobes could also be the primary pathway for the entrance of SARS-CoV-2 into the brain.
SARS-CoV-2 can lead to neurological complications, such as cerebrovascular manifestations, motor movement complications, and cognitive decline. COVID-19 infection can result in cerebrovascular symptoms and diseases, such as strokes and thrombosis. The virus can affect the neural system, disrupt cognitive function and cause neurological disorders. To combat the epidemic, it is crucial to repurpose drugs currently in use quickly and develop novel therapeutics.
严重急性呼吸综合征冠状病毒(SARS)、中东呼吸综合征(MERS)和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)等冠状病毒与包括严重呼吸系统疾病在内的危重疾病有关。SARS-CoV-2 是致命的 COVID-19 疾病的病原体,该疾病已在全球范围内蔓延成为大流行。SARS-CoV-2 可能通过嗅球进入人体,并与血管紧张素转换酶 2(ACE2)受体相互作用,从而进一步促进细胞结合和进入细胞。有报道称,该病毒可以穿过血脑屏障(BBB)并进入中枢神经系统(CNS),导致各种疾病。SARS-CoV-2 通过细胞进入主要依赖于 TMPRSS2 和组织蛋白酶 L,它们激活 S 蛋白。TMPRSS2 存在于呼吸道、胃肠道和泌尿生殖道上皮的细胞表面,而组织蛋白酶-L 是内体的一部分。
本综述旨在提供有关 SARS-CoV-2 感染如何影响大脑功能的信息。此外,还讨论了与 SARS-CoV-2 感染相关的中枢神经系统疾病,包括缺血性中风、脑静脉血栓形成、格林-巴利综合征、多发性硬化症、脑膜炎和脑炎。详细阐述了 COVID 患者发生脑血管问题的多种可能机制和途径。
有报道称,SARS-CoV-2 病毒可以穿过血脑屏障(BBB)并进入中枢神经系统(CNS),从而导致多种疾病。患有 COVID-19 的患者会出现一系列神经系统并发症,包括睡眠障碍、病毒性脑炎、头痛、味觉障碍和认知障碍。有报道称 COVID-19 患者的脑脊液(CSF)中存在 SARS-CoV-2。健康专家还报告了在大脑皮层神经元和人类脑类器官中存在 SARS-CoV-2。病毒渗透到大脑的可能机制可以是神经嗜性、直接渗透和细胞因子风暴途径。嗅球也可能是 SARS-CoV-2 进入大脑的主要途径。
SARS-CoV-2 可导致神经系统并发症,如血管表现、运动运动并发症和认知能力下降。COVID-19 感染可导致脑血管症状和疾病,如中风和血栓形成。该病毒可影响神经系统,扰乱认知功能并引起神经紊乱。为了抗击这一流行病,快速重新利用现有的药物并开发新的疗法至关重要。